Key Efficacy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Key Efficacy. Real-time updates on events, politics, business and more.

Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide

September 20, 2023

SLS-002 demonstrated early and persistent clinically meaningful reductions in symptoms of depression and acute suicidality Robust Response and Remission Rates were observed using the...

New York United States Davidv Sheehan Tim Whitaker Anthony Marciano Lifesci Advisors

Source: marketscreener.com

PD-1 and PD-L1 Evolution, Navigating through Lines of Therapy; Market Outlook, Competitive Landscape, Drug Utilization, and Market Forecast by cancer Types

January 8, 2022

PD-1 and PD-L1 Evolution, Navigating through Lines of Therapy; Market Outlook, Competitive Landscape, Drug Utilization, and Market Forecast by cancer Types

United States United Kingdom Insight Report Company Current Global Drug Development Pipeline Thelansis Knowledge Partners Bengaluru Embassy Techvillage

Source: texasguardian.com

PD-1 and PD-L1 Evolution, Navigating through Lines of Therapy; Market Outlook, Competitive Landscape, Drug Utilization, and Market Forecast by cancer Types

January 8, 2022

PD-1 and PD-L1 Evolution, Navigating through Lines of Therapy; Market Outlook, Competitive Landscape, Drug Utilization, and Market Forecast by cancer Types

United States United Kingdom Insight Report Company Current Global Drug Development Pipeline Thelansis Knowledge Partners Bengaluru Embassy Techvillage

Source: sandiegosun.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Key Efficacy News Today

Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide

PD-1 and PD-L1 Evolution, Navigating through Lines of Therapy; Market Outlook, Competitive Landscape, Drug Utilization, and Market Forecast by cancer Types

PD-1 and PD-L1 Evolution, Navigating through Lines of Therapy; Market Outlook, Competitive Landscape, Drug Utilization, and Market Forecast by cancer Types

Explore More Categories